XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Millions
Total
Accumulated other comprehensive income (loss)
Consolidated Entity Excluding Consolidated Funds
Total stockholders’ equity (deficit)
Consolidated Entity Excluding Consolidated Funds
Common Stock
Consolidated Entity Excluding Consolidated Funds
Additional paid-in capital
Consolidated Entity Excluding Consolidated Funds
Retained earnings (deficit)
Consolidated Entity Excluding Consolidated Funds
Accumulated other comprehensive income (loss)
Consolidated Funds
Beginning balance (in shares) at Dec. 31, 2021       45,400,000        
Beginning balance at Dec. 31, 2021   $ (10.8) $ (17.6) $ 0.0 $ 0.0 $ (6.8) $ (10.8)  
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)       200,000        
Repurchase of common stock (in shares) (4,147,450)     (4,200,000)        
Repurchase of common stock $ (100.0)   (103.2)     (103.2)    
Equity-based compensation     1.8   1.8      
Foreign currency translation adjustment (5.6)   (5.6)       (5.6)  
Amortization related to derivatives securities, net of tax     2.8       2.8  
Withholding tax related to stock option exercise and restricted stock vesting (2.3)   (2.3)   (0.9) (1.4)    
Dividends     (1.2)     (1.2)    
Net income     70.2     70.2    
Ending balance (in shares) at Sep. 30, 2022       41,400,000        
Ending balance at Sep. 30, 2022   (13.6) (55.1) $ 0.0 0.9 (42.4) (13.6)  
Beginning balance at Dec. 31, 2021               $ 0.0
Increase (Decrease) in redeemable non-controlling interest in consolidated Funds                
Net income     70.2     70.2    
Ending balance at Sep. 30, 2022               0.0
Beginning balance at Dec. 31, 2021 (17.6)              
Increase (Decrease) in total equity and redeemable non-controlling interest in consolidated Funds                
Issuance of common stock 0.0              
Repurchase of common stock (103.2)              
Equity-based compensation 1.8              
Foreign currency translation adjustment (5.6)              
Amortization related to derivative securities, net of tax 2.8              
Dividends (1.2)              
Net income 70.2              
Ending balance at Sep. 30, 2022 (55.1)              
Beginning balance (in shares) at Jun. 30, 2022       41,400,000        
Beginning balance at Jun. 30, 2022   (11.7) (71.0) $ 0.0 0.5 (59.8) (11.7)  
Increase (Decrease) in Stockholders' Equity                
Equity-based compensation     0.4   0.4      
Foreign currency translation adjustment (2.5)   (2.5)       (2.5)  
Amortization related to derivatives securities, net of tax     0.6       0.6  
Dividends     (0.4)     (0.4)    
Net income     17.8     17.8    
Ending balance (in shares) at Sep. 30, 2022       41,400,000        
Ending balance at Sep. 30, 2022   (13.6) (55.1) $ 0.0 0.9 (42.4) (13.6)  
Beginning balance at Jun. 30, 2022               0.0
Increase (Decrease) in redeemable non-controlling interest in consolidated Funds                
Net income     17.8     17.8    
Ending balance at Sep. 30, 2022               0.0
Beginning balance at Jun. 30, 2022 (71.0)              
Increase (Decrease) in total equity and redeemable non-controlling interest in consolidated Funds                
Equity-based compensation 0.4              
Foreign currency translation adjustment (2.5)              
Amortization related to derivative securities, net of tax 0.6              
Dividends (0.4)              
Net income 17.8              
Ending balance at Sep. 30, 2022 (55.1)              
Beginning balance (in shares) at Dec. 31, 2022       41,400,000        
Beginning balance at Dec. 31, 2022   (10.6) (21.6) $ 0.0 1.5 (12.5) (10.6)  
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)       100,000        
Equity-based compensation     1.0   1.0      
Foreign currency translation adjustment 0.6   0.6       0.6  
Amortization related to derivatives securities, net of tax     1.9       1.9  
Withholding tax related to stock option exercise and restricted stock vesting (0.7)   (0.7)   (0.7)      
Dividends     (1.3)     (1.3)    
Net income     43.0     43.0   0.3
Ending balance (in shares) at Sep. 30, 2023       41,500,000        
Ending balance at Sep. 30, 2023   (8.1) 22.9 $ 0.0 1.8 29.2 (8.1)  
Beginning balance at Dec. 31, 2022               0.0
Increase (Decrease) in redeemable non-controlling interest in consolidated Funds                
Capital contributions (9.9)             (9.9)
Net de-consolidation of Funds               (1.9)
Net income     43.0     43.0   0.3
Ending balance at Sep. 30, 2023               8.3
Beginning balance at Dec. 31, 2022 (21.6)              
Increase (Decrease) in total equity and redeemable non-controlling interest in consolidated Funds                
Issuance of common stock 0.0              
Capital contributions (9.9)             (9.9)
Equity-based compensation 1.0              
Foreign currency translation adjustment 0.6              
Amortization related to derivative securities, net of tax 1.9              
Net de-consolidation of Funds (1.9)              
Dividends (1.3)              
Net income 43.3              
Ending balance at Sep. 30, 2023 31.2              
Beginning balance (in shares) at Jun. 30, 2023       41,500,000        
Beginning balance at Jun. 30, 2023   (7.9) 3.7 $ 0.0 1.5 10.1 (7.9)  
Increase (Decrease) in Stockholders' Equity                
Equity-based compensation     0.3   0.3      
Foreign currency translation adjustment (0.9)   (0.9)       (0.9)  
Amortization related to derivatives securities, net of tax     0.7       0.7  
Dividends     (0.5)     (0.5)    
Net income     19.6     19.6   0.2
Ending balance (in shares) at Sep. 30, 2023       41,500,000        
Ending balance at Sep. 30, 2023   $ (8.1) 22.9 $ 0.0 $ 1.8 29.2 $ (8.1)  
Beginning balance at Jun. 30, 2023               2.3
Increase (Decrease) in redeemable non-controlling interest in consolidated Funds                
Capital contributions (7.7)             (7.7)
Net de-consolidation of Funds               (1.9)
Net income     $ 19.6     $ 19.6   0.2
Ending balance at Sep. 30, 2023               8.3
Beginning balance at Jun. 30, 2023 6.0              
Increase (Decrease) in total equity and redeemable non-controlling interest in consolidated Funds                
Capital contributions (7.7)             $ (7.7)
Equity-based compensation 0.3              
Foreign currency translation adjustment (0.9)              
Amortization related to derivative securities, net of tax 0.7              
Net de-consolidation of Funds (1.9)              
Dividends (0.5)              
Net income 19.8              
Ending balance at Sep. 30, 2023 $ 31.2